COVID-19 is forcing European laboratories to re-think where they test patients. Some are working with authorities to set up new ‘drive-through’ testing points, while others have closed more than half of their drawing points.
In the second of our two-part deep dive into how COVID-19 is hitting healthcare markets across EMEA, we ask how hospitals are coping with spiralling staff sickness and a flood of patients, and whether the care and dialysis sectors can stay afloat given the risk the virus poses to their most vulnerable patients.
Germany is on the brink of reforming the financing of long-term care insurance (LTC) which funds elderly care. The industrious Federal Minister of Health Jens Spahn could produce a draft law by the summer, and private insurers are proposing revolutionary ways of bringing fresh capital to the system.
Germany's second-largest private hospital group Asklepios plans to launch a takeover of listed competitor Rhoen Klinikum in partnership with Rhoen's founder Eugene Muench. But Rhoen's shares have now risen above the offer price indicating this is far from a done deal.
PE backed Swiss hospital and psychiatric group Ameos has acquired a majority stake in a not-for-profit hospital, its second facility in the country. The group, predominantly present in Germany and Austria, is taking advantage of a challenging climate in the Swiss hospital sector which is putting many small hospitals in financial trouble.
Hospitals and insurers have been looking for consolidated digital health platforms ever since they grew tired of 'pilotitus' from a fragmented market. But what if they could become a central administrator to an "ecosystem" where thousands of start-ups become third-party plug-ins? Biesdorf is convinced that this is about to happen in Germany.
German hospital operator Rhoen Klinikum 2019 sales grew three times faster than the previous year, but EBITDA was flat and is expected to fall substantially in 2020. Its move to outpatient is helping the top-line. HBI considers these results and board-level developments expected later this year.
Occupational healthcare groups Medicover and Terveystalo are growing revenue at upwards of 25%, much faster than the 6-9% seen in other publicly listed groups so far this year. Historically employer-funded, individual pay is now growing three times faster than corporate. With Fresenius Helios setting out occupational healthcare expansion plans, what is the future of corporate pay?
Listed dialysis, pharma and hospital group Fresenius has seen a 6% jump in its share price after 2019 results were better than some analysts expected. But with significant Asia exposure in certain businesses, CEO Stephan Sturm says: "Coronavirus is not going to be a positive for us."
Dr Markus Hamm, the former CEO of family-owned German hospital group Schoen-Kliniken, has a new role as group CEO of German ophthalmology group Ober Scharrer. What does this say about the company’s plans?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.